GEODE CAPITAL MANAGEMENT, LLC

Position in ELTX — Elicio Therapeutics, Inc.

CIK 1214717 BOSTON, MA

Position in ELTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,217,393

-$227,509 QoQ

Shares Held

311,354

+130.4% QoQ

Ownership

1.18%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 48 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. ELTX ranks #310 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,217,393	311,354	+130.4%	Shares	Defined	2026-08-12
2026-03-31	$1,444,902	135,164	+2.0%	Shares	Defined	2026-05-15
2025-12-31	$1,054,842	132,518	+2.2%	Shares	Defined	2026-02-09
2025-09-30	$1,418,764	129,686	+7.3%	Shares	Defined	2025-11-12
2025-06-30	$932,815	120,831	+56.0%	Shares	Defined	2025-08-08
2025-03-31	$477,195	77,467	+9.5%	Shares	Defined	2025-05-13
2024-12-31	$360,677	70,721	-1.2%	Shares	Defined	2025-02-12
2024-09-30	$360,016	71,574	+0.1%	Shares	Defined	2024-11-12
2024-06-30	$293,897	71,508	+49.9%	Shares	Defined	2024-08-09
2024-03-31	$362,489	47,696	+7.6%	Shares	Defined	2024-05-13
2023-12-31	$369,828	44,344	+59.1%	Shares	Defined	2024-02-13
2023-09-30	$235,535	27,874	+15.3%	Shares	Defined	2023-11-13
2023-06-30	$229,605	24,169	—	Shares	Defined	2023-08-11
No filing history on record for this holder in this stock.